Population trends in BMD testing, treatment, and hip and wrist fracture rates: are the hip fracture projections wrong?

被引:153
作者
Jaglal, SB
Weller, I
Mamdani, M
Hawker, G
Kreder, H
Jaakkimainen, L
Adachi, JD
机构
[1] Univ Toronto, Dept Rehabil Sci, Toronto, ON M5G 1V7, Canada
[2] Inst Clin Evaluat Sci, Toronto, ON, Canada
[3] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada
[4] Sunnybrook & Womens Coll Hlth Sci Ctr, Osteoporosis Res Program, Toronto, ON, Canada
[5] Sunnybrook & Womens Coll Hlth Sci Ctr, Dept Orthopaed, Toronto, ON, Canada
[6] Univ Toronto, Dept Publ Hlth Sci, Toronto, ON, Canada
[7] Univ Toronto, Fac Pharm, Toronto, ON, Canada
[8] Univ Toronto, Dept Med, Toronto, ON, Canada
[9] Univ Toronto, Dept Surg, Toronto, ON, Canada
[10] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada
[11] McMaster Univ, St Josephs Hosp, Dept Med, Hamilton, ON, Canada
关键词
hip fracture; incidence; bone densitometry; osteoporosis; wrist fracture;
D O I
10.1359/JBMR.041231
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A worldwide epidemic of hip fractures has been predicted. Time trends in BMD testing, bone-sparing medications and hip and wrist fractures in the province of Ontario, Canada, were examined. From 1996 to 2001, BMD testing and use of bone-sparing medications increased each year, whereas despite the aging of the population, wrist and hip fracture rates decreased. Introduction: If patients with osteoporosis are being diagnosed and effective treatments used with increasing frequency in the population, rates of hip and wrist fractures will remain stable or possibly decrease. We report here time trends in BMD testing, prescriptions for bone-sparing medications, hip and wrist fracture rates, and population projections of fracture rates to 2005 in the province of Ontario, Canada. Materials and Methods: Ontario residents have universal access to Medicare. To examine time trends in BMD testing, all physician claims for DXA from 1992 to 2001 were selected from the Ontario Health Insurance Plan (OHIP) database. Trends in prescribing were examined from 1996 to 2003 using data from the Ontario Drug Benefit plan, which provides coverage to persons >= 65 years of age. Actual numbers of hip and wrist fractures were determined for 1992-2000 and population projections for 2001-2005 using time-series analysis. Wrist fractures were identified in the OHIP database and hip fractures through hospital discharge abstracts. Results: From 1992 to 2001, the number of BMD tests increased 10-fold. There has been a steady increase in the number of persons filling prescriptions for antiresorptives (12,298 in 1996 to 225,580 in 2003) and the majority were for etidronate. For women, the rate of decline for wrist fractures is greater than that for hip fractures. The rate of hip fracture was fairly constant around 41 per 10,000 women :50 years between 1992 and 1996. In 1997, the hip fracture rate began to decrease, and the population projections suggest that this downward trend will continue to a rate of 33.1 per 10,000 in 2005. Conclusions: Our findings suggest that fracture rates may be on the decline, despite the aging of the population, because of increased patterns of diagnosis and treatment for osteoporosis.
引用
收藏
页码:898 / 905
页数:8
相关论文
共 61 条
  • [41] *NAT OST FDN, 1998, PHYS GUID PREV TREAT
  • [42] *ONT HLTH INS PLAN, 1999, B BON DENS TEST
  • [43] *ONT MIN HLTH, 2004, ONT DRUG BEN FORM CO
  • [44] PAPADIMITROPOULOS, 1997, CAN MED ASSOC J, V157, P1357
  • [45] Papaioannou A, 1998, CAN MED ASSOC J, V159, P1253
  • [46] Initiation of hormone replacement therapy after diagnosis of osteoporosis by bone densitometry
    Phillipov, G
    Mos, E
    Scinto, S
    Phillips, PJ
    [J]. OSTEOPOROSIS INTERNATIONAL, 1997, 7 (02) : 162 - 164
  • [47] Pindyck RobertS., 2013, MICROECONOMICS
  • [48] Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass:: Results of the FOSIT study
    Pols, HAP
    Felsenberg, D
    Hanley, DA
    Stepán, J
    Muñoz-Torres, M
    Wilkin, TJ
    Qin-sheng, G
    Galich, AM
    Vandormael, K
    Yates, AJ
    Stych, B
    [J]. OSTEOPOROSIS INTERNATIONAL, 1999, 9 (05) : 461 - 468
  • [49] INCIDENCE OF HIP FRACTURE IN SASKATCHEWAN, CANADA, 1976-1985
    RAY, WA
    GRIFFIN, MR
    WEST, R
    STRAND, L
    MELTON, LJ
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1990, 131 (03) : 502 - 509
  • [50] Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis
    Reginster, JY
    Minne, HW
    Sorensen, OH
    Hooper, M
    Roux, C
    Brandi, ML
    Lund, B
    Ethgen, D
    Pack, S
    Roumagnac, I
    Eastell, R
    [J]. OSTEOPOROSIS INTERNATIONAL, 2000, 11 (01) : 83 - 91